Inventor
Katherine CYGNAR
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
C12NMicroorganisms or enzymes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A01KAnimal husbandry6%
C12YEnzymes6%
C40BCombinatorial chemistry3%
PatentTitleYear
12,297,257Multispecific antigen-binding molecules and uses thereof202512,258,597Methods and compositions for therapeutic protein delivery202512,252,544Anti-CD63 antibodies, conjugates, and uses thereof202512,215,138Compositions and methods for internalizing enzymes202511,696,572Non-human animals comprising a humanized ASGR1 locus202311,352,446Methods of making multispecific antigen-binding molecules202211,208,458Compositions and methods for internalizing enzymes202111,191,844Multispecific antigen-binding molecules and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to REGENERON PHARMA (8)· patent assignee history
2021Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 8 | 2021–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |